Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 24  •  01:15PM ET
37.24
Dollar change
+0.18
Percentage change
0.47
%
CategoryGlobal or ExUS Equities - Industry Sector Asset TypeEquities (Stocks) TagsGlobal Return% 1Y28.42% Total Holdings65 Perf Week2.59%
SponsorFranklin Templeton ETF Type Tagsequity Return% 3Y7.02% AUM22.24M Perf Month-1.41%
Fund Family Bond Type Tagshealthcare Return% 5Y-2.90% NAV/sh Perf Quarter24.77%
Index- Average Maturity Tagsgenomics Return% 10Y 52W High38.11 -2.28% Perf Half Y36.57%
Index Weighting Commodity Type Tags- Return% SI 52W Low23.74 56.87% Perf YTD29.09%
Active/Passive Quant Type Tags- Flows% 1M0.00% Volatility0.47% 0.61% Perf Year23.53%
Dividend TTM- ESG Type Tags- Flows% 3M8.02% ATR (14)0.39 Perf 3Y21.76%
Dividend Ex-DateDec 30, 2021 Dividend Type Sector/Theme Flows% YTD24.78% RSI (14)58.45 Perf 5Y-12.10%
Dividend Gr. 3/5Y- - Structure Type Region Flows% 1Y Beta1.04 Perf 10Y-
Expense0.50% Growth/Value SMA200.35% Flows% 3Y Rel Volume0.14 Prev Close37.07
Inverse/Leveraged Market Cap SMA504.15% Flows% 5Y Avg Volume3.33K Price37.24
IPOFeb 27, 2020 Option/ShortYes / No SMA20023.86% Trades Volume461 Change0.47%
Nov-25-25 03:44AM
Nov-24-25 10:00AM
Nov-21-25 08:00AM
May-02-25 03:25AM
Apr-30-25 04:35AM
05:45AM Loading…
Apr-23-25 05:45AM
Apr-20-25 11:28AM
Apr-18-25 01:40PM
Apr-04-25 08:30AM
Apr-02-25 07:00AM
Apr-01-25 05:40AM
Mar-28-25 06:05AM
Mar-20-25 04:32PM
Jul-16-21 11:19AM
Jan-14-21 09:15AM
08:00AM Loading…
Oct-05-20 08:00AM
Franklin Genomic Advancements ETF seeks capital appreciation. Under normal market conditions, the fund invests at least 80% of its net assets in equity securities of companies that are relevant to its investment theme of genomic advancements. The fund invests predominantly in common stock. Although it may invest across economic sectors, the fund concentrates its investments in health care related industries. It is non-diversified.